{"schema_version":"1","generated_at":"2026-11-08T18:30:01.426Z","data_as_of":null,"url":"https://www.findmykol.com/kol/paz-vellanki","json_url":"https://www.findmykol.com/kol/paz-vellanki/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"paz-vellanki","name":"Paz Vellanki","credential":"MD, PhD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"United States Food and Drug Administration","institution_url":"https://www.findmykol.com/institution/united-states-food-and-drug-administration","city":"Silver Spring","state":"MD","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1447699681","orcid":"0000-0003-0782-7935","openalex":"A5069024194"},"summary":"Paz Vellanki is an Oncology physician affiliated with United States Food and Drug Administration. OpenAlex indexes 19 publications with 519 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":19,"cited_by_count":519,"h_index":10,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"ABBVIE INC.","program_year":2024,"amount_usd":32.49,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1447699681"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1447699681","source":"payments"},"publications":{"total":19,"shown":5,"withheld":14,"matched_by":"OpenAlex author record","recent":[{"title":"Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical utility study","year":2026,"journal":"medRxiv","source_url":"https://doi.org/10.64898/2026.02.18.26346415","status":"verified"},{"title":"Landmark ctDNA Molecular Response Represents an Early Predictor of Immunotherapy Outcomes in Lung Cancer: A Clinical Validity Study","year":2026,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-26-0656","status":"verified"},{"title":"FDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating HER2 mutations","year":2024,"journal":"The Oncologist","source_url":"https://doi.org/10.1093/oncolo/oyae151","status":"verified"},{"title":"Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group","year":2024,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-24-1883","status":"verified"},{"title":"The Retrofit: Lessons From Sotorasib's Dosing Conundrum","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.24.00310","status":"verified"}],"source":"works"},"similar":[{"name":"Richard Pazdur","slug":"richard-pazdur","institution":"United States Food and Drug Administration","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/richard-pazdur","json_url":"https://www.findmykol.com/kol/richard-pazdur/profile.json"},{"name":"Ann Farrell","slug":"ann-farrell","institution":"United States Food and Drug Administration","specialty":"Hematology","url":"https://www.findmykol.com/kol/ann-farrell","json_url":"https://www.findmykol.com/kol/ann-farrell/profile.json"},{"name":"Marc Theoret","slug":"marc-theoret","institution":"United States Food and Drug Administration","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/marc-theoret","json_url":"https://www.findmykol.com/kol/marc-theoret/profile.json"},{"name":"Adrian Senderowicz","slug":"adrian-senderowicz","institution":"United States Food and Drug Administration","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/adrian-senderowicz","json_url":"https://www.findmykol.com/kol/adrian-senderowicz/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":14}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}